ARMISTICE CAPITAL LLC 13D and 13G filings for Rigel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:46 pm Purchase | 2025-03-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 1,516,000 8.480% | 364,000 (+31.60%) | Filing |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 1,152,000 6.540% | -384,000 (-25.00%) | Filing |
| 2024-11-14 5:18 pm Sale | 2024-09-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | ARMISTICE CAPITAL LLC | 1,536,000 8.730% | -174,000 (-10.18%) | Filing |